EIB and ProCredit unlock €65 million to speed the recovery of small and medium sized companies in the Western Balkans from the COVID-19 crisis

The EIB and the ProCredit group have agreed on a new €65 million credit line to support small and medium enterprises (SMEs) in the Western Balkans and to speed their recovery from the COVID-19 crisis. This transaction provides much-needed financing to companies in Serbia, Albania, North Macedonia and Bosnia & Herzegovina and addresses their working capital, liquidity and investment needs in the face of the ongoing pandemic. In parallel, the operation strengthens the regional banking sector and reinforces its ability to finance the economic recovery of the Western Balkans.

€10 million to develop next-generation industrial monitoring solution

The EIB will provide a €10 million financing to support the R&D strategy of the Spanish scale-up Worldsensing, a widely recognised Internet of Things (IoT) pioneer that focuses on designing IoT solutions for monitoring sensors and operates in more than 60 countries. The EIB long-term and advantageous financing of Worldsensing will support the company's innovation efforts aimed at increasing its production capabilities, developing a portfolio of new products and at enhancing the company’s commercial and distribution network.  The agreement was announced today at Web Summit by EIB Vice-President Ricardo Mourinho Félix and Worldsensing CFO David Deprez.

Poland: EIB provides additional support to chemical company PCC Rokita

The Bank will increase the financing provided at the beginning of last year to €67.5 million. The funds will support the company’s modernisation plans and the construction of the Process Innovation and Scaling Centre. Both loan agreements are backed by an EFSI guarantee under the Investment Plan for Europe

Spain: Biotech innovation – the EIB provides €20 million in financing to Sanifit to develop treatments for vascular calcification

The EIB is set to support the development of new treatments for progressive vascular calcification, an area of significant unmet medical need where there are currently no approved treatments. To this end, the EU bank will provide a €20 million loan to Spanish biopharmaceutical company Sanifit, which is developing novel treatments in two disease indications linked to calcification.

Translate »

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more